Ernesto Maddaloni

Pubblicazioni

Titolo Pubblicato in Anno
Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes EXPERT OPINION ON INVESTIGATIONAL DRUGS 2021
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity ENDOCRINE 2021
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS 2021
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study JOURNAL OF DIABETES RESEARCH 2021
Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk DIABETOLOGIA 2021
Usefulness of Color Doppler Ultrasonography in the Risk Stratification of Thyroid Nodules EUROPEAN THYROID JOURNAL 2021
Correction to: "H" for Heterogeneity in the Algorithm for Type 2 Diabetes Management CURRENT DIABETES REPORT 2020
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86) THE LANCET DIABETES & ENDOCRINOLOGY 2020
Effects of covid-19 lockdown on glucose control: continuous glucose monitoring data from people with diabetes on intensive insulin therapy DIABETES CARE 2020
Adult-onset autoimmune diabetes in 2020: An update MATURITAS 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) DIABETES RESEARCH AND CLINICAL PRACTICE 2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) CARDIOVASCULAR DIABETOLOGY 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I) DIABETES RESEARCH AND CLINICAL PRACTICE 2020
Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics DIABETES/METABOLISM RESEARCH AND REVIEWS 2020
The vicious circle of left ventricular dysfunction and diabetes: From pathophysiology to emerging treatments THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2020
Implementing the treatment of heart failure with SGLT-2 inhibitors and sacubitril-valsartan: does money matter? EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2020
Risk factors and predictive biomarkers of early cardiovascular disease in obese youth DIABETES/METABOLISM RESEARCH AND REVIEWS 2019
Cardiovascular effects of SGLT-2 inhibitors: What we have learned from cardiovascular outcome trials and what we still need to understand DIABETES/METABOLISM RESEARCH AND REVIEWS 2019
Risk factors for fragility fractures in type 1 diabetes BONE 2019
Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies DIABETES/METABOLISM RESEARCH AND REVIEWS 2019

Progetti di Ricerca

Gruppi di ricerca

Intervento farmacologico inibente la differenziazione delle cellule mieloidi verso un fenotipo calcificante
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine
Synergies anchoring to gravity (SynErg): a novel test to diagnose risk of falls in type 2 diabetes patients

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma